Back to Journals » Clinical Interventions in Aging » Volume 5

Risk of “silent stroke” in patients older than 60 years: risk assessment and clinical perspectives

Authors Lim, Kwon HM

Published 2 September 2010 Volume 2010:5 Pages 239—251


Review by Single anonymous peer review

Peer reviewer comments 3

Jae-Sung Lim1, Hyung-Min Kwon2

1Department of Neurology, Armed Forces Seoul Hospital, Seoul, Republic of Korea; 2Department of Neurology, Seoul National University Boramae Hospital, Seoul, Republic of Korea

Abstract: With the increasing size of the elderly population and evolving imaging technology, silent brain infarction (SBI) has garnered attention from both the public and the physicians. Over 20% of the elderly exhibit SBI, and the prevalence of SBI increases steadily with age, ie, 30%–40% in those older than 70 years. Well-known cardiovascular risk factors such as hypertension has been identified as a risk factor of SBI (odds ratio [OR] = 3.47) Besides this, blood pressure (BP) reactivity to mental stress, morning BP surges, and orthostatic BP changes have been demonstrated to contribute to the presence of SBI. Further, a metabolic syndrome not only as a whole syndrome (OR = 2.18) but also as individual components could have an influence on SBI. Increased C-reactive protein and interleukin-6, coronary artery disease, body mass index, and alcohol consumption have also been associated with SBI. The ORs and ­possible mechanisms have been discussed in this article. Overt stroke, dementia, depression, and aspiration pneumonia were all associated with SBI. (overt stroke: hazard ratio [HR] = 1.9, 95% confidence interval [CI]; 1.2–2.8; dementia: HR = 2.26, 95% CI: 1.09–4.70). We also looked into their close relationship with SBI in this review.

silent brain infarction, elderly, risk factors, treatment

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.